Relationship of tissue and cellular interleukin-1 and lipopolysaccharide after endotoxemia and bacteremia.
暂无分享,去创建一个
R. Ezzell | H. S. Warren | B. D. Clark | P. Loiselle | S. Amato | Y. Ge | H. Warren
[1] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[2] S. Brown,et al. Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. , 1993, The Journal of biological chemistry.
[3] H. Northoff,et al. Production of tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the perfused rat liver. , 1993, European cytokine network.
[4] J. Mier,et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. , 1993, Journal of immunology.
[5] S. Calvano,et al. Comparison of Peripheral Blood Leukocyte Kinetics After Live Escherichia coli, Endotoxin, or Interleukin‐1 α Administration Studies Using a Novel Interleukin‐1 Receptor Antagonist , 1993, Annals of Surgery.
[6] J. Mannick,et al. Cytokines, sepsis and immunomodulation , 1993, The British journal of surgery.
[7] D. Laskin,et al. Characterization of interleukin‐1 and interleukin‐6 production by hepatic endothelial cells and macrophages , 1993, Journal of leukocyte biology.
[8] James Allen,et al. Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing. , 1992, Journal of immunology.
[9] R. Munford,et al. Acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides, has phospholipase, lysophospholipase, diacylglycerollipase, and acyltransferase activities in vitro. , 1992, The Journal of biological chemistry.
[10] C. Newton,et al. Continuous Endotoxin Infusion Suppresses Rat Spleen Cell Production of Cytokines , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[11] J. Haas,et al. In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. , 1992, Immunology.
[12] I. Bedrosian,et al. Detection of interleukin 1α and 1β in rabbit tissues during endotoxemia using sensitive radioimmunoassays , 1991 .
[13] J. Cavaillon,et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. , 1991, The Journal of clinical investigation.
[14] D. Remick,et al. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. , 1991, The American journal of pathology.
[15] K. Glaser,et al. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. , 1990, The Journal of clinical investigation.
[16] S. Reed,et al. IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha. , 1989, Journal of immunology.
[17] P. Wingfield,et al. Rabbit IL-1. Cloning, expression, biologic properties, and transcription during endotoxemia. , 1989, Journal of immunology.
[18] D. Hazuda,et al. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. , 1988, The Journal of biological chemistry.
[19] T. Ikejima,et al. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.
[20] T. Strom,et al. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. , 1987, Journal of immunology.
[21] H. Colten,et al. Macrophage membrane interleukin 1 regulates the expression of acute phase proteins in human hepatoma Hep 3B cells. , 1987, Journal of immunology.
[22] T. Hopp,et al. Localization of human mononuclear cell interleukin 1. , 1987, Journal of immunology.
[23] A. C. Webb,et al. Transcriptional regulation of the human prointerleukin 1 beta gene. , 1987, Journal of immunology.
[24] C. Lang,et al. Glucose kinetics and development of endotoxin tolerance during long-term continuous endotoxin infusion. , 1987, Metabolism: clinical and experimental.
[25] R. Munford,et al. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. , 1986, Science.
[26] T. Luger,et al. Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsis , 1986, Critical care medicine.
[27] H. Young,et al. Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin. , 1986, Journal of immunology.
[28] G. Nossal,et al. Interleukin 1 can act as a B-cell growth and differentiation factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Unanue,et al. Relationship of macrophage Ia and membrane IL 1 expression to antigen presentation. , 1985, Journal of immunology.
[30] R. Munford,et al. Uptake and deacylation of bacterial lipopolysaccharides by macrophages from normal and endotoxin-hyporesponsive mice , 1985, Infection and immunity.
[31] E. Unanue,et al. Identification of a membrane-associated interleukin 1 in macrophages. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[32] D. Morrison,et al. The fate of E. coli lipopolysaccharide after the uptake of E. coli by murine macrophages in vitro. , 1984, Journal of immunology.
[33] R. Munford,et al. Enzymatic deacylation of the lipid A moiety of Salmonella typhimurium lipopolysaccharides by human neutrophils. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. J. Staruch,et al. The adjuvanticity of interleukin 1 in vivo. , 1983, Journal of immunology.
[35] J. Bemiller,et al. Methods in Carbohydrate Chemistry , 1965 .
[36] P. Beeson. TOLERANCE TO BACTERIAL PYROGENS : I. FACTORS INFLUENCING ITS DEVELOPMENT , 1947 .
[37] R. Tompkins,et al. Cellular distribution of endotoxin after injection of chemically purified lipopolysaccharide differs from that after injection of live bacteria. , 1994, The Journal of infectious diseases.
[38] M. Brandon,et al. Production and in vivo use of recombinant ovine IL-1 beta as an immunological adjuvant. , 1994, Vaccine.
[39] L. Boros,et al. Interleukin‐1α gene expression and localization of interleukin‐1α protein during tumor promotion , 1993 .
[40] C. Galanos,et al. Metabolic fate of endotoxin in rat. , 1990, Advances in experimental medicine and biology.
[41] C. Dinarello. Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.
[42] K. Tanamoto,et al. Uptake and deacylation of bacterial lipopolysaccharides in cultured rat hepatocytes. , 1988, Progress in clinical and biological research.
[43] E. Döpp,et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. , 1985, Advances in experimental medicine and biology.